Diagnosing Respiratory Disease in Children Using Cough Sounds 2



Status:Completed
Conditions:Asthma, Bronchitis, Pneumonia, Pulmonary, Pulmonary, Pulmonary
Therapuetic Areas:Pulmonary / Respiratory Diseases
Healthy:No
Age Range:Any - 12
Updated:11/10/2018
Start Date:January 5, 2018
End Date:October 19, 2018

Use our guide to learn which trials are right for you!

Diagnosing Respiratory Disease in Children Using Smartphone Recordings of Cough Sounds 2

The purpose of this prospective study is to evaluate the efficacy of the ResAppDx software
application in the diagnosis of childhood acute respiratory disease, including pneumonia,
bronchiolitis, asthma/reactive airways disease, croup, lower respiratory tract disease
(LRTD), viral lower respiratory tract infection (vLRTI), and upper respiratory tract disease
(URTD).


Inclusion Criteria:

- Infant or child aged greater than 29 days up to and including their 12th birthday
(infant and children pediatric subgroups as defined in Guidance for Industry and Food
and Drug Administration Staff: Premarket Assessment of Pediatric Medical Devices dated
March 24, 2014)

- Presenting to the study site (an outpatient facility, an urgent care center, an
Emergency Department, or inpatient ward within 24 hours of admission) with current
signs or symptoms of respiratory disease including cough, wheezing, stridor, chest
in-drawing/retractions, difficulty breathing, fast breathing, nasal
congestion/rhinorrhea, abnormal lung sounds on exam or cyanosis/hypoxemia.

- Onset of symptoms within past 14 days

- Outpatient or inpatient within 24 hours of admission

- Coughing spontaneously or able to cough voluntarily

Exclusion Criteria:

- Lack of a signed consent form from parent or legal guardian

- Lack of signed assent form for children aged 7 years or older who, in the opinion of
the investigator, is able to provide assent based on their age, maturity or
psychological state.

- Need for mechanical ventilatory support ((including invasive, CPAP, or BiPAP)) or high
flow nasal cannula

- History of structural airways abnormalities, tracheobronchomalacia, or vocal cord
abnormalities (e.g. laryngomalacia, tracheomalacia, or bronchomalacia)

- Any medical contraindication to voluntary cough, including the following (only enroll
if coughing spontaneously): severe respiratory distress, history of pneumothorax,
eye/chest/abdominal surgery in past 3 months, hemoptysis in the past month

- Too medically unstable to participate in study per treating clinician

- Subject previously enrolled in SMARTCOUGH-C-2 study

- Tracheostomy present or tube placed
We found this trial at
3
sites
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Peter P Moschovis, MD MPH
Phone: 617-643-9687
?
mi
from
Boston, MA
Click here to add this to my saved trials
Cleveland, Ohio
Principal Investigator: John C Carl, MD
Phone: 216-444-3916
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
6621 Fannin St
Houston, Texas 77030
(832) 824-1000
Principal Investigator: Esther M Sampayo, MD MPH
Phone: 832-824-6512
Texas Children's Hospital Texas Children's Hospital, located in Houston, Texas, is a not-for-profit organization whose...
?
mi
from
Houston, TX
Click here to add this to my saved trials